Abstract
Choreiform involuntary movements, “dyskinesia,” are a manifestation of chronic levodopa treatment in Parkinson’s disease. Levodopa-induced chorea presents as brief, irregular, non-rhythmic, flowing, involuntary movements. Risk factors for levodopa- induced dyskinesia include younger age of onset of Parkinson’s disease, greater disease severity, higher levodopa dose, longer duration of levodopa treatment, and female gender. Patients can have varying frequency and severity of dyskinesia. Treatment options for patients with disabling dyskinesia include adjusting the levodopa dose and daily dosing schedule, amantadine, intraduodenal levodopa, and deep brain stimulation.In this chapter, a case of a 69-year-old woman with longstanding Parkinson’s disease on chronic levodopa treatment is discussed, including the disease course, differential diagnosis, workup, and treatment outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
